Spago Nanomedical board resolves to seek delisting from Nasdaq First North Growth Market

The Board of Directors of Spago Nanomedical has resolved, subject to approval of the general meeting, to apply for delisting from the Nasdaq First North Growth Market.

Detected & updated continuously · Source: Nebula